4//SEC Filing
LaBarre Michael J. 4
Accession 0001415889-25-005899
CIK 0001159036other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:32 PM ET
Size
14.7 KB
Accession
0001415889-25-005899
Insider Transaction Report
Form 4
LaBarre Michael J.
VP, Product Development
Transactions
- Sale
Common Stock
2025-02-26$58.09/sh−9,400$546,055→ 176,053 total - Sale
Common Stock
2025-02-27$58.74/sh−100$5,874→ 173,756 total - Sale
Common Stock
2025-02-25$58.67/sh−700$41,069→ 185,453 total - Sale
Common Stock
2025-02-25$58.01/sh−9,300$539,465→ 186,153 total - Sale
Common Stock
2025-02-26$58.65/sh−600$35,189→ 175,453 total - Sale
Common Stock
2025-02-27$58.25/sh−1,597$93,028→ 173,856 total
Footnotes (6)
- [F1]The sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2024.
- [F2]Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.54 to $58.47. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.54 to $58.91. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.62 to $58.61. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.62 to $58.68. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]Represents a weighted average sales price per share. These shares were sold at prices ranging from $57.71 to $58.66. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001507174
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:32 PM ET
- Size
- 14.7 KB